Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy.
Wyluda EJ, Cheng J, Schell TD, Haley JS, Mallon C, Neves RI, Robertson G, Sivik J, Mackley H, Talamo G, Drabick JJ. Wyluda EJ, et al. Among authors: schell td. Cancer Biol Ther. 2015;16(5):662-70. doi: 10.1080/15384047.2015.1026507. Cancer Biol Ther. 2015. PMID: 25806780 Free PMC article.
Malignant melanoma-The cradle of anti-neoplastic immunotherapy.
Koller KM, Wang W, Schell TD, Cozza EM, Kokolus KM, Neves RI, Mackley HB, Pameijer C, Leung A, Anderson B, Mallon CA, Robertson G, Drabick JJ. Koller KM, et al. Among authors: schell td. Crit Rev Oncol Hematol. 2016 Oct;106:25-54. doi: 10.1016/j.critrevonc.2016.04.010. Epub 2016 May 7. Crit Rev Oncol Hematol. 2016. PMID: 27637351 Review.
Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity.
Kokolus KM, Haley JS, Koubek EJ, Gowda R, Dinavahi SS, Sharma A, Claxton DF, Helm KF, Drabick JJ, Robertson GP, Neighbors JD, Hohl RJ, Schell TD. Kokolus KM, et al. Among authors: schell td. Oncoimmunology. 2018 Nov 11;8(2):e1539614. doi: 10.1080/2162402X.2018.1539614. eCollection 2019. Oncoimmunology. 2018. PMID: 30713799 Free PMC article.
Drug-Tolerant Persister Cells in Cancer Therapy Resistance.
Dhanyamraju PK, Schell TD, Amin S, Robertson GP. Dhanyamraju PK, et al. Among authors: schell td. Cancer Res. 2022 Jul 18;82(14):2503-2514. doi: 10.1158/0008-5472.CAN-21-3844. Cancer Res. 2022. PMID: 35584245 Free PMC article. Review.
Tumor Heterogeneity Shapes Survival Dynamics in Drug-Treated Cells, Revealing Size-Drifting Subpopulations.
Vangala V, Chen YC, Dinavahi SS, Gowda K, Lone NA, Herlyn M, Drabick J, Helm K, Zhu J, Neves RI, Sharma AK, Berg A, Archetti M, Amin S, Schell TD, Robertson GP. Vangala V, et al. Among authors: schell td. ACS Pharmacol Transl Sci. 2024 Oct 17;7(11):3573-3584. doi: 10.1021/acsptsci.4c00453. eCollection 2024 Nov 8. ACS Pharmacol Transl Sci. 2024. PMID: 39539277
86 results